Merck & Co acquires Elanco's fish health unit for $1.3bn, enabling Elanco to focus on pet health and livestock sustainability.

Merck & Co. has agreed to acquire Elanco Animal Health Inc.'s fish health unit for $1.3 billion in cash. The purchase will allow Merck to gain access to key products for warm and cold-water fish species, which generated about $175 million in revenue in 2023. Elanco plans to use the expected proceeds from the sale to pay down debt.

February 05, 2024
21 Articles

Further Reading